EGFR and central nervous system cancer: Because this question cannot be readily determined in xenograft tumors in situ, we have addressed this question in cell culture, using well-defined pharmacological treatments and three human glioma lines: U87MG, U87+EGFR, and U87+EGFRvIII [42,45,46].